More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
Author:
Affiliation:
1. Postgraduate Medical School, University of Hertfordshire, United Kingdom
2. Pharmacology, Catholic University School of Medicine, Rome, Italy
3. National Heart & Lung Institute Imperial College, London, United Kingdom
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/JAHA.117.007754
Reference53 articles.
1. Acute Coronary Syndromes: Diagnosis and Management, Part I
2. Bivalirudin during Primary PCI in Acute Myocardial Infarction
3. Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding
4. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: A meta-analysis of randomized controlled trials
5. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug‐eluting stent implantation for coronary heart disease: results of the CILON‐T (influence of CILostazol‐based triple antiplatelet therapy ON ischemic complication after drug‐eluting stenT implantation) trial;Suh JW;J Am Coll Cardiol,2011
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study;Thrombosis Research;2024-04
2. ORAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROMES, CLINICAL EXPERIENCE IN AN EMERGENCY HOSPITAL WITH PERCUTANEOUS CORONARY INTERVENTION FACILITIES;FARMACIA;2021-10-30
3. Left main coronary artery thrombus after cannabis consumption: a case report;European Heart Journal - Case Reports;2021-05-29
4. Recurrent Stent Thrombosis: An Interventionalist’s Nightmare;Journal of the American Heart Association;2021-05-04
5. Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome;Medicine;2021-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3